Trupanion (NASDAQ:TRUP) released its quarterly earnings results on Tuesday. The financial services provider reported ($0.05) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.02) by ($0.03), Yahoo Finance reports. Trupanion had a negative return on equity of 7.41% and a negative net margin of 1.05%. The company had revenue of $66.55 million for the quarter, compared to analysts’ expectations of $65.60 million.

Trupanion (NASDAQ TRUP) traded up $0.12 during trading hours on Wednesday, reaching $31.27. The company’s stock had a trading volume of 413,900 shares, compared to its average volume of 309,264. The stock has a market capitalization of $935.74, a PE ratio of -347.41 and a beta of 0.34. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.87 and a quick ratio of 1.87. Trupanion has a 1 year low of $13.88 and a 1 year high of $36.88.

In other Trupanion news, insider Asher Bearman sold 4,039 shares of the stock in a transaction on Tuesday, November 21st. The stock was sold at an average price of $28.40, for a total value of $114,707.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Ian Moffat sold 7,000 shares of the stock in a transaction on Monday, November 27th. The stock was sold at an average price of $30.06, for a total value of $210,420.00. Following the completion of the transaction, the chief operating officer now owns 7,000 shares of the company’s stock, valued at approximately $210,420. The disclosure for this sale can be found here. Insiders sold 25,039 shares of company stock valued at $775,403 in the last quarter. 31.24% of the stock is currently owned by company insiders.

Several equities research analysts have recently commented on TRUP shares. Zacks Investment Research upgraded Trupanion from a “hold” rating to a “buy” rating and set a $37.00 price target for the company in a research note on Wednesday, November 8th. Canaccord Genuity restated a “buy” rating and set a $35.00 price target (up previously from $29.00) on shares of Trupanion in a research note on Tuesday, October 31st. BidaskClub upgraded Trupanion from a “sell” rating to a “hold” rating in a research note on Tuesday, December 12th. Northland Securities restated a “buy” rating and set a $38.00 price target on shares of Trupanion in a research note on Thursday, February 8th. Finally, CL King started coverage on Trupanion in a research note on Tuesday, November 21st. They set a “neutral” rating for the company. One analyst has rated the stock with a sell rating, two have given a hold rating and seven have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $35.57.

COPYRIGHT VIOLATION WARNING: This story was reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The legal version of this story can be accessed at https://theolympiareport.com/2018/02/14/trupanion-trup-releases-quarterly-earnings-results-misses-expectations-by-0-03-eps.html.

About Trupanion

Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.

Earnings History for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.